Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Viola Vaccarino
After many years of neglect, interest in the area of ischemic heart disease in women has grown over the past 20 years. This growing interest has been in part stimulated by campaigns by leading health organizations to increase awareness of this problem among the public, the health care providers, and the researchers. Despite these efforts, awareness of cardiovascular risk remains low among women, some disparities in management persist, and inclusion of women in cardiovascular clinical trials still substantially lags that of men. Additionally, although research papers on ischemic heart disease in women have grown, there are still substantial gaps in our understanding of the pathophysiology, risk factors, preventive strategies and effective treatments for women.
Many reviews, monographs and position papers have been published on various aspects of heart disease in women. We think that these activities have been useful in driving attention to this important area, but limited data substantiate many of these statements. We need to recognize these limitations in order to guide future progress. Key questions concerning sex differences in pathophysiology, presentation and outcomes of ischemic heart disease remain unanswered, as are those pertaining to strategies for prevention and treatment of heart disease in women. A comprehensive evaluation of the achievements, as well as the gaps that still remain in this field is needed. This is what we want to achieve with this paper.
The Working Group will review current knowledge supporting sex differences in the pathophysiology, presentation and treatment of ischemic heart disease. A detailed description of the state of the science, with recognition of the shortcomings of current data, will be developed. Based on our review, we will articulate recommendations for future research.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 BIOT
06903Sophia Antipolis, FR
© 2017 European Society of Cardiology. All rights reserved